Jianyong Yang

570 total citations · 1 hit paper
27 papers, 402 citations indexed

About

Jianyong Yang is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Jianyong Yang has authored 27 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 8 papers in Surgery and 6 papers in Oncology. Recurrent topics in Jianyong Yang's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease and Transplantation (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Jianyong Yang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease and Transplantation (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Jianyong Yang collaborates with scholars based in China and United States. Jianyong Yang's co-authors include Jiaping Li, Yonghui Huang, Wenzhe Fan, Yingqiang Zhang, Wenquan Zhuang, Wenqiang Lou, Yu Wang, Yao Wang, Sirui Fu and Ligong Lu and has published in prestigious journals such as PLoS ONE, Nanoscale and The Journal of Urology.

In The Last Decade

Jianyong Yang

26 papers receiving 397 citations

Hit Papers

A comprehensive review of advances in physics-informed ne... 2024 2026 2025 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianyong Yang China 12 202 98 96 86 60 27 402
Stephanie K. Schaub United States 12 203 1.0× 204 2.1× 29 0.3× 99 1.2× 124 2.1× 48 516
Y Kawashima Japan 12 57 0.3× 120 1.2× 62 0.6× 217 2.5× 103 1.7× 55 594
H. Hashii Japan 14 138 0.7× 363 3.7× 95 1.0× 279 3.2× 86 1.4× 18 688
Nainesh Parikh United States 11 91 0.5× 209 2.1× 24 0.3× 114 1.3× 60 1.0× 24 376
Carmen Cutolo Italy 14 181 0.9× 120 1.2× 24 0.3× 134 1.6× 154 2.6× 35 545
B. Adam United States 9 97 0.5× 261 2.7× 35 0.4× 124 1.4× 140 2.3× 13 519
Gianluca Maria Varano Italy 13 83 0.4× 187 1.9× 39 0.4× 174 2.0× 104 1.7× 38 487
Xiaodong Zhou China 13 198 1.0× 54 0.6× 23 0.2× 158 1.8× 34 0.6× 31 498
P Schneider United States 7 162 0.8× 108 1.1× 20 0.2× 84 1.0× 73 1.2× 17 406
Mu-Tai Liu Taiwan 13 75 0.4× 183 1.9× 37 0.4× 97 1.1× 76 1.3× 24 403

Countries citing papers authored by Jianyong Yang

Since Specialization
Citations

This map shows the geographic impact of Jianyong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianyong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianyong Yang more than expected).

Fields of papers citing papers by Jianyong Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianyong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianyong Yang. The network helps show where Jianyong Yang may publish in the future.

Co-authorship network of co-authors of Jianyong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jianyong Yang. A scholar is included among the top collaborators of Jianyong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianyong Yang. Jianyong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lou, Wenqiang, et al.. (2024). A comprehensive review of advances in physics-informed neural networks and their applications in complex fluid dynamics. Physics of Fluids. 36(10). 49 indexed citations breakdown →
4.
Dai, Haitao, Bin Chen, Guiyuan Zhang, et al.. (2021). Prognostic value of splenic volume in hepatocellular carcinoma patients receiving transarterial chemoembolization. Journal of Gastrointestinal Oncology. 12(3). 1141–1151. 3 indexed citations
5.
Chen, Song, et al.. (2020). Efficacy and Safety of Transarterial Chemoembolization Combined With Anlotinib for Unresectable Hepatocellular Carcinoma: A Retrospective Study. Technology in Cancer Research & Treatment. 19. 1079233235–1079233235. 18 indexed citations
6.
Fan, Wenzhe, Guosheng Yuan, Fuliang Li, et al.. (2019). Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study. Clinical Therapeutics. 41(8). 1463–1476. 39 indexed citations
7.
Huang, Yonghui, Bin Chen, Ni Liu, et al.. (2017). Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis. International Journal of Clinical Pharmacology and Therapeutics. 55(6). 498–508. 10 indexed citations
9.
Li, Nan, Bin Chen, Run Lin, et al.. (2017). The earlier, the better: the effects of different administration timepoints of sorafenib in suppressing the carcinogenesis of VEGF in rats. Cancer Chemotherapy and Pharmacology. 81(1). 207–216. 4 indexed citations
10.
Fan, Wenzhe, Yingqiang Zhang, Yao Wang, et al.. (2017). Is Emergency Transcatheter Hepatic Arterial Embolization Suitable for Spontaneously Ruptured Hepatocellular Carcinoma in Child–Pugh C Cirrhosis?. Journal of Vascular and Interventional Radiology. 29(3). 404–412.e3. 9 indexed citations
11.
Fan, Wenzhe, Lizhi Niu, Yingqiang Zhang, et al.. (2016). Initial Experience: Alleviation of Pain with Percutaneous CT–Guided Cryoablation for Recurrent Retroperitoneal Soft-Tissue Sarcoma. Journal of Vascular and Interventional Radiology. 27(12). 1798–1805. 11 indexed citations
12.
Cheang, Tuck−Yun, Hongyan Zhou, Wei Chen, et al.. (2016). C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer. Journal of Translational Medicine. 14(1). 54–54. 6 indexed citations
13.
Zhang, Yingqiang, Wenzhe Fan, Kangshun Zhu, et al.. (2015). Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma after a complete response. Oncotarget. 6(27). 24550–24559. 7 indexed citations
14.
Zhang, Yingqiang, Wenzhe Fan, Yu Wang, et al.. (2015). Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis. The Oncologist. 20(12). 1417–1424. 60 indexed citations
15.
Li, Jiaping, Fujun Zhang, Jianyong Yang, et al.. (2014). Combination of individualized local control and target-specific agent to improve unresectable liver cancer managements: a matched case-control study. Targeted Oncology. 10(2). 287–295. 9 indexed citations
16.
Jin, Yi, Dayue Tong, Jianning Chen, et al.. (2012). Overexpression of Osteopontin, αvβ3 and Pim-1 Associated with Prognostically Important Clinicopathologic Variables in Non-Small Cell Lung Cancer. PLoS ONE. 7(10). e48575–e48575. 27 indexed citations
17.
Fan, Wenzhe, Jianyong Yang, Ming‐De Lu, et al.. (2011). [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors].. PubMed. 91(31). 2190–4. 12 indexed citations
18.
Li, Jiaping, Jianping Chu, Zhi Li, et al.. (2010). Characterizing Clinicopathological Findings of Transarterial Chemoembolization for Wilms Tumor. The Journal of Urology. 183(3). 1138–1145. 4 indexed citations
19.
Liu, Shuo, et al.. (2009). Fertilization effect on fruiting of young Jatropha curcas plantations.. 29(3). 11–14. 1 indexed citations
20.
Chu, Jianping, Wei Chen, Jiaping Li, et al.. (2007). Clinicopathologic Features and Results of Transcatheter Arterial Chemoembolization for Osteosarcoma. CardioVascular and Interventional Radiology. 30(2). 201–206. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026